Announcement on Progress of Matters Regarding Company Stock Being Subject to Other Risk Warnings and Potential Delisting Risk Warnings

ST Jiaying Co., Ltd.·July 29, 2026·3 pages

✨ AI Summary

This announcement details the progress of Guangdong Jiaying Pharmaceutical Co., Ltd. in addressing internal control issues that led to risk warnings. The company is implementing corrective measures, focusing on financial management and internal control deficiencies, to aim for the removal of the "ST" designation. Production and operations remain normal.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Securities Code: 002198

Securities Abbreviation: ST Jiaying

Guangdong Jiaying Pharmaceutical Co., Ltd.

Announcement Number: 2026-032

Announcement on Progress of Matters Regarding Company Stock Being Subject to Other Risk Warnings and Potential Delisting Risk Warnings

The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information in this announcement, and that there are no false records, misleading statements, or material omissions.

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.